{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Pragmatic Ischaemic Thrombectomy Evaluation (PISTE) Trial: A Randomised Controlled Trial"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Participants were randomised 1:1 to receive IVT alone or IVT plus MT, using a minimisation algorithm."
      },
      "Participants": {
        "score": 2,
        "evidence": "Adult patients with acute ischaemic stroke, confirmed large artery occlusion on CT angiography, and IVT initiated within 4.5 hours of symptom onset were eligible."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Participants were randomised 1:1 to receive IVT alone or IVT plus MT."
      },
      "Objective": {
        "score": 1,
        "evidence": "The PISTE trial aimed to assess the efficacy of adjunctive intra-arterial mechanical thrombectomy (MT) in addition to intravenous thrombolysis (IVT) for acute ischaemic stroke with large artery occlusion."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was independence at day 90, defined by a modified Rankin Scale (mRS) score of 0\u20132."
      },
      "Randomisation_Allocation": {
        "score": 1,
        "evidence": "Participants were randomised 1:1 to receive IVT alone or IVT plus MT, using a minimisation algorithm."
      },
      "Blinding": {
        "score": 1,
        "evidence": "Outcome assessors were blinded."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "Sixty-five patients were randomised between April 2013 and April 2015, with 32 receiving IVT alone and 33 receiving IVT plus MT."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "In the intention-to-treat analysis, no significant difference was observed in the primary outcome."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "In the intention-to-treat analysis, no significant difference was observed in the primary outcome (adjusted OR 2.12, 95% CI 0.65 to 6.94, p=0.20)."
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events were similar between groups, with no significant safety concerns."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: NCT01745692."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 20,
    "max_score": 25
  },
  "model": "gpt-4o"
}